New York attorney general targets devil's claw makers in probe of herbal supplements industry

ALBANY, N.Y. – New York’s attorney general is demanding 13 manufacturers stop selling an obscure herbal remedy called devil’s claw because DNA tests found samples contained a plant species different from the plant on their labels.

Attorney General Eric Schneiderman (SHNEYE’-dur-muhn) says in letters sent Wednesday to manufacturers that DNA studies by the New York Botanical Garden found the supplements for arthritis contained a cheaper related species.

Schneiderman says he reached an agreement with a 14th manufacturer to improve procedures to ensure its devil’s claw contains only the labeled species.

American Botanical Council industry group founder Mark Blumenthal says the two species noted by Schneiderman are almost identical and are considered interchangeable in devil’s claw products.

Schneiderman’s actions are part of an ongoing investigation of the herbal supplement industry.